Part D Proposal Aims To Promote Biosimilars, Generics To Reduce Costs
Executive Summary
Medicare Part D proposed rule would lower cost sharing for biosimilars to the level of generics for some beneficiaries, allow immediate generic substitution for plans.
You may also be interested in...
Part D Plan To Adjust Cost Sharing For Biosimilars Questioned By PhRMA
PhRMA suggests that treating biosimilars like generics in some cases could lead to confusion and may have little impact on cost sharing for beneficiaries.
Part D Plan To Adjust Cost Sharing For Biosimilars Questioned By PhRMA
PhRMA suggests that treating biosimilars like generics in some cases could lead to confusion and may have little impact on cost sharing for beneficiaries.
Medicare May Require Part D Plans To Provide Point-of-Sale Rebates
CMS outlines possible approach to point-of-sale rebates in Medicare Part D, recognizing that using rebates to lower cost sharing for 'many' would increase premiums for all.